tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tenax Therapeutics to hold a conference call
PremiumThe FlyTenax Therapeutics to hold a conference call
2M ago
Tenax Therapeutics Reports Increased R&D Expenses Amid Clinical Trials
Premium
Company Announcements
Tenax Therapeutics Reports Increased R&D Expenses Amid Clinical Trials
2M ago
Tenax Therapeutics reports Q3 EPS (40c), consensus ($1.12)
Premium
The Fly
Tenax Therapeutics reports Q3 EPS (40c), consensus ($1.12)
2M ago
Tenax announces EPO intention to grant patent for levosimendan in PH-HFpEF
PremiumThe FlyTenax announces EPO intention to grant patent for levosimendan in PH-HFpEF
4M ago
Tenax Therapeutics Expands Licensing Agreement with Orion
Premium
Company Announcements
Tenax Therapeutics Expands Licensing Agreement with Orion
4M ago
Promising Potential of Tenax Therapeutics’ TNX-103 Drives Buy Rating Amid Positive Phase 2 Results and Anticipated Phase 3 Trial
Premium
Ratings
Promising Potential of Tenax Therapeutics’ TNX-103 Drives Buy Rating Amid Positive Phase 2 Results and Anticipated Phase 3 Trial
4M ago
Tenax Therapeutics trading halted, volatility trading pause
PremiumThe FlyTenax Therapeutics trading halted, volatility trading pause
7M ago
Tenax Therapeutics Approves Officer Exculpation Amendment
Premium
Company Announcements
Tenax Therapeutics Approves Officer Exculpation Amendment
7M ago
Tenax Therapeutics Reports Increased Losses Amid Strategic Investments
Premium
Company Announcements
Tenax Therapeutics Reports Increased Losses Amid Strategic Investments
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100